Infinera Corporation (NASDAQ: INFN) today released financial results for its third quarter ended September 28, 2024. GAAP revenue for the quarter was ...
Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales more than doubled year over year to $3.1 billion. Sales for Zepbound, which ...
Revenue of $2.6 billion, up 3% on an as-reported and FX-Neutral basis Gross Merchandise Volume of $18.3 billion, up 2% on an as-reported basis and up 1% on an FX-Neutral ...
(Nasdaq: HMST) (including its consolidated subsidiaries, the "Company", "HomeStreet" or "we"), the parent company of HomeStreet Bank, today announced the financial results for the quarter ended ...